ARCHIVES

Schilskly Promoted to Associate Dean At Chicago, Vogelzang To Direct Center

This article is from The Cancer Letter archive.

Vol. 25 No. 09 | March 5, 1999

Download PDF Visit The Full Archive

Related Articles

NCI Cancer Bulletin publicized board’s resignation over liability concerns.

April 16, 2004

Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says.

May 7, 2004

DePinho Bets MD Anderson Credibility On His Cancer “Moon Shot” Program

September 7, 2012

New Chemotherapy, Other Modality Progress Described

March 30, 1979

DeVita Heads U.S. Board Of CCCR

August 4, 1989

Indoor Tanning Industry Funded Author Of NEJM Review On Vitamin D Deficiency.

April 18, 2008